Journals / Göztepe Tıp Dergisi / 2006 / Cilt: 21 - Sayı: 3

Anemia and heart failure

Anemi ve kalp yetersizliği

Pages
138–141
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, the anemia is often in heart failure and acompaning diseases increase anemia frequancy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Congestive heart failure, is still cardiovasculer disease having the worst prognosis, in spite of the developments in the diagnosis and the treatment.
📊
Key Findings & Data:So, to be defining the factors effecting bad the prognosis and life quality and to be devoloping the new treatment strategies against these factors, is very important.
💡
Conclusion & Impact:In conclusion, the anemia is often in heart failure and acompaning diseases increase anemia frequancy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Congestive heart failure, is still cardiovasculer disease having the worst prognosis, in spite of the developments in the diagnosis and the treatment. So, to be defining the factors effecting bad the prognosis and life quality and to be devoloping the new treatment strategies against these factors, is very important. Anemia is the reason for cardiomyopathy in itself. Furthermore, it worsens both heart failure and nephrophaty in heart failure. Also the anemia decreases surviving and life quality. It increases hospitalization at the elderly patients with heart failure.In this study, 71 patients with heart failure who had hospitalized were analysed retrospective. The anemia was finded % 35 of the patients. Most of these were chronic disease anemia. The anemia ratio was higher in women, in elderly patients, in patients with high creatinin level, hypertension and ischemic heart disease. There was no relation between anemia and ejection fraction both men and women.Although anemia is a well defined co-morbidity in a lot of conditions, its role in the heart failure is being remarkable currently. In conclusion, the anemia is often in heart failure and acompaning diseases increase anemia frequancy. To diagnose anemia early and to treat it early is very important in patients with heart failure. Treating anemia improves considerable level the prognosis and life quality of the patients.

Özet

Konjestif kalp yetersizliği (KKY), tanı ve tedavideki tüm gelişmelere rağmen hala prognozu en kötü kardiyovasküler hastalıktır. Bu nedenle, kalp yetersizliğinde yaşam kalitesi ve prognozu kötü yönde etkileyen faktörlerin belirlenmesi ve bunlara yönelik tedavi stratejilerinin belirlenmesi çok önemlidir. Anemi, başlıbaşına bir kardiyomiyopati nedenidir. Dahası, hem konjestif kalp yetersizliğini hem de kalp yetersizliğinde nefropatiyi kötüleştirir. Ayrıca, kalp yetersizliğinde sağkalımı ve yaşam kalitesini azaltır. Yaşlı kalp yetersizlikli hastalarda hospitalizasyonları artırır.Bu çalışmada, konjestif kalp yetersizliği tanısıyla yatarak tedavi edilmiş 71 hasta retrospektif olarak incelendi. Hastaların % 35'inde anemi tespit edildi. Bunların çoğu kronik hastalık anemisiydi. Anemi, kadınlarda, yaşlı hastalarda, kreatinin düzeyi yüksek olanlarda, hipertansif hastalarda, iskemik kalp hastalığı (İKH) olanlarda anlamlı derecede yüksek saptandı. Hem kadınlarda, hem erkeklerde anemi ve ejeksiyon fraksiyonu arasında herhangi bir ilişki saptanmadı.Anemi, birçok durumda iyi tanımlanmış bir komorbidite olmasına rağmen kalp yetersizliğindeki rolü daha yeni dikkat çekmektedir. Sonuç olarak, kalp yetersizliğinde anemi sıktır. Eşlik eden ek bir hastalık sıklığını artırır. Kalp yetersizlikli hastalarda aneminin erken tespiti ve erken tedavi edilmesi çok önemlidir. Aneminin tedavi edilmesiyle, hastaların yaşam kalitesi ve prognozu önemli derecede düzelmektedir.

🔖

Cite This Article

PİŞKİNPAŞA, M. E., ÖNER, A. F., ERGÜNEY, M., TAŞKIRAN, H. (2022). Anemia and heart failure. Göztepe Tıp Dergisi, Cilt: 21 - Sayı: 3, 138–141. https://ajindex.com/articles/526355

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Silverberg DS, Wexler D, Blum M, et al: The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class and markedly reduces hospitalisations. J Am Coll Cardiol 35:1737-44, 2000
  2. Rigatto C, Parfrey P, Foley R, et al: Congestive heart failure in renal transplant recipients: risk factors, outcomes and relationship with ischemic heart disease. J Am Soc Nephrol. 13:1084-90, 2002
  3. Metivier F, Marchais SJ, Guerin AP, et al: Pathophysiology of anemia: focus on the heart and blood vessels. Nephrol Dial Transplant. 15 Suppl 3:14-18, 2000
  4. Ghali JK: Anemia and poor prognosis in advanced heart failure. J Am Coll Cardiol 40:2204, 2002
  5. Silverberg DS, Wexler D, lana A: The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail 4:681 -86, 2002
  6. Ezekowitz JA, McAlister FA, Armstrong PW: Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12065 patients with new-onset heart failure. Circulation 107:223-225, 2003
  7. Lipschitz D: Medical and functional consequences of anemia in the elderly. J Am Geriatr Soc 51:10-13, 2003
  8. Horwich TB, Fonarow GC, Hamilton MA, et al: Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced haert failure. J Am Coll Cardiol 39:1780-86, 2002
  9. Wexler D, Silverberg DS, Sheps D, lana A: The importance of correction anemi with erytropoietin and intravenous iron in severe resistant congestive heart failure. Europa J Heart Fail. Suppl 2/2:225-230, 2003
  10. Schafer GE, Rehbein C, Stiegler T, et al: Renal anemia and its hemodynamic response findings invasively determined over a period of 20 years. Clin Nephrol 58(Suppl l):52-57, 2002
  11. Gomez JM, Carrera F: What should optima target hemoglobin be? Kidney Int Suppl:39-43, 2002
  12. Mancini DM, Eisen H, Kusmaul W, et al: Value of peak exercise oxigen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83(3):778-786, 1991.